Dermatomyositis

A type of idiopathic inflammatory myopathy characterized by evocative skin lesions and symmetrical proximal muscle weakness.

Myositis

A general term for inflammation of the muscles without respect to the underlying cause.


Total: 103

                       


(per page)
PMID (PMCID)
31153385
 OTHER
Paraneoplastic dermatomyositis appearing after nivolumab therapy for gastric cancer: a case report.
Shibata C, Kato J, Toda N, Imai M, Fukumura Y, Arai J, Kurokawa K, Kondo M, Takagi K, Kojima K, Ohki T, Seki M, Yoshida M, Suzuki A, Tagawa K.
J Med Case Rep. 2019;13(1):168.
We experienced such a case in which we had difficulties in diagnosing paraneoplastic dermatomyositis or drug-associated myositis.
31153385
 OTHER
Paraneoplastic dermatomyositis appearing after nivolumab therapy for gastric cancer: a case report.
Shibata C, Kato J, Toda N, Imai M, Fukumura Y, Arai J, Kurokawa K, Kondo M, Takagi K, Kojima K, Ohki T, Seki M, Yoshida M, Suzuki A, Tagawa K.
J Med Case Rep. 2019;13(1):168.
While dermatomyositis is often associated with malignancy, several autoimmune diseases like myositis can be caused by immune checkpoint inhibitors.
31153385
 OTHER
Paraneoplastic dermatomyositis appearing after nivolumab therapy for gastric cancer: a case report.
Shibata C, Kato J, Toda N, Imai M, Fukumura Y, Arai J, Kurokawa K, Kondo M, Takagi K, Kojima K, Ohki T, Seki M, Yoshida M, Suzuki A, Tagawa K.
J Med Case Rep. 2019;13(1):168.
Differentially diagnosing paraneoplastic dermatomyositis or drug-associated myositis caused by immune checkpoint inhibitors is difficult in some cases.
31153385
 OTHER
Paraneoplastic dermatomyositis appearing after nivolumab therapy for gastric cancer: a case report.
Shibata C, Kato J, Toda N, Imai M, Fukumura Y, Arai J, Kurokawa K, Kondo M, Takagi K, Kojima K, Ohki T, Seki M, Yoshida M, Suzuki A, Tagawa K.
J Med Case Rep. 2019;13(1):168.
Differentially diagnosing malignancy-associated dermatomyositis or myositis caused by immune checkpoint inhibitors is sometimes difficult, particularly when a patient with malignancy shows the symptoms of myositis after checkpoint inhibitor administration.
31153385
 OTHER
Paraneoplastic dermatomyositis appearing after nivolumab therapy for gastric cancer: a case report.
Shibata C, Kato J, Toda N, Imai M, Fukumura Y, Arai J, Kurokawa K, Kondo M, Takagi K, Kojima K, Ohki T, Seki M, Yoshida M, Suzuki A, Tagawa K.
J Med Case Rep. 2019;13(1):168.
Differentially diagnosing malignancy-associated dermatomyositis or myositis caused by immune checkpoint inhibitors is sometimes difficult, particularly when a patient with malignancy shows the symptoms of myositis after checkpoint inhibitor administration.
29287518
 MALE Middle Aged
Anti-MDA5 positive dermatomyositis complicated with rapidly progressive interstitial lung disease - a case report.
De Backer E, Gremonprez F, Brusselle G, Depuydt P, Van Dorpe J, Van Haverbeke C, Goeminne PC, Derom E.
Acta Clin Belg. 2018;73(6):413-417.
Myositis specific antibodies (MSA) can be used for diagnosis and predicting prognosis in patients with polymyositis and dermatomyositis.
30042104
 FEMALE Adult
Double-positive with positive anti-glomerular basement membrane antibody and ANCA-positive disease in a patient with dermatomyositis.
Dein EJ, Crespo-Bosque M, Timlin H, Geetha D.
BMJ Case Rep. 2018;2018:.
Approximately one in four patients (23.3%) with inflammatory myositis including dermatomyositis can require evaluation for acute kidney injury.
29571300
(5866516)
 FEMALE Middle Aged
Erythroderma and extensive poikiloderma - a rare initial presentation of dermatomyositis: a case report.
Herath HMMTB, Keragala BSDP, Pahalagamage SP, Janappriya GHCC, Kulatunga A, Gunasekera CN.
J Med Case Rep. 2018;12(1):83.
Electromyography and muscle biopsy were supportive of inflammatory myositis and skin biopsy showed evidence of dermatomyositis.
30583602
 OTHER
Heart⁻Lung⁻Muscle Anti-SAE Syndrome: An Atypical Severe Combination.
Zamora E, Seder-Colomina E, Holgado S, Quirant-Sanchez B, Mate JL, Martinez-Caceres EM, Casafont I, Bayes-Genis A.
J Clin Med. 2018;8(1):.
A comprehensive immune work-up revealed anti-small ubiquitin-like modifier-1 activating enzyme (anti-SAE) antibody, a novel myositis-specific antibody, previously described mainly with overt cutaneous dermatomyositis and late skeletal muscle manifestations.
30632536
 OTHER
Histological Findings of Organizing Pneumonia, Based on Transbronchial Lung Biopsy, May Predict Poor Outcome in Polymyositis and Dermatomyositis: Report of Two Autopsied Cases.
Oiwa H, Kondo T, Funaki M, Morito T, Yasui H, Kamiya T.
Arch Rheumatol. 2018;33(3):376-380.
Our experience indicates that transbronchial biopsy findings of organizing pneumonia may be a poor prognostic factor in clinically amyopathic dermatomyositis and polymyositis, in spite of the profile of myositis-specific antibodies.
29464127
(5804115)
 OTHER
Use of High-Flow Nasal Cannula Oxygen Therapy in a Pregnant Woman with Dermatomyositis-Related Interstitial Pneumonia.
Shoji T, Umegaki T, Nishimoto K, Anada N, Ando A, Uba T, Kusunoki M, Oku K, Kamibayashi T.
Case Rep Crit Care. 2017;2017:4527597.
The patient's condition improved after 7 days of hospitalization; by this time, she was positive for myositis-specific autoantibodies and was diagnosed with interstitial pneumonia preceding dermatomyositis.
28668260
 FEMALE
[Amyopathic dermatomyositis (DM) with anti-MDA5 antibodies, associated with bullous pemphigoid, Sjogren syndrome and gastric MALT lymphoma].
Garcia B, Dabouz F, Pascal L, Gillard M, Modiano P.
Ann Dermatol Venereol. 2017;144(10):629-633.
The inflammatory myopathies are a heterogeneous group of muscle diseases and comprise polymyositis, dermatomyositis (DM), myopathies associated with cancers, necrotising myositis and inclusion body myositis.
26759443
 FEMALE Middle Aged
Colonic vasculopathy and perforation in the initial presentation of adult dermatomyositis in a patient with improving muscle weakness.
Kibbi N, Bekui A, Buckley LM.
BMJ Case Rep. 2016;2016:.
Muscle biopsy confirmed myositis, and serological studies were consistent with dermatomyositis (DM), without evidence of overlapping connective tissue disease or malignancy.
24638953
(4145214)
 MALE Middle Aged
Dermatomyositis as a complication of interferon-alpha therapy: a case report and review of the literature.
Shiba H, Takeuchi T, Isoda K, Kokunai Y, Wada Y, Makino S, Hanafusa T.
Rheumatol Int. 2014;34(9):1319-22.
We made a diagnosis of dermatomyositis according to these clinical features, proximal muscle-predominant myogenic change on electromyography, and infiltration of monocytes and CD4+-dominant lymphocytes on skin biopsy, although myositis-associated antibodies were absent.
25347903
 FEMALE Adult
[Inflammatory myopathy with initial respiratory muscles involvement and rheumatoid arthritis].
Hunter M, Telias I, Collado V, Sarano J, Alvarez C, Suarez JP.
Medicina (B Aires). 2014;74(5):393-6.
The most common inflammatory myopathies seen in practice can be separated into four distinct subsets: polymyositis, dermatomyositis, necrotizing autoimmune myositis and inclusion body myositis.
23423441
 MALE Middle Aged
Antisynthetase antibody syndrome: case report and review of the literature.
Uribe L, Ronderos DM, Diaz MC, Gutierrez JM, Mallarino C, Fernandez-Avila DG.
Clin Rheumatol. 2013;32(5):715-9.
This diagnosis should always come to mind in patients that present with signs of myositis, dermatomyositis, or polymyositis associated with interstitial lung disease.
22618987
 FEMALE Middle Aged
Living-donor lobar lung transplantation for rapidly progressive interstitial pneumonia associated with clinically amyopathic dermatomyositis: report of a case.
Shoji T, Bando T, Fujinaga T, Chen F, Sasano H, Yukawa N, Mimori T, Date H.
Gen Thorac Cardiovasc Surg. 2013;61(1):32-4.
The manifestations of collagen disease are variable and dermatomyositis (DM) is often considered a contraindication for lung transplantation because of active myositis and a high incidence of malignancy.
22515579
 FEMALE
Hydroxyurea-induced dermatomyositis: true amyopathic dermatomyositis or dermatomyositis-like eruption?
Nofal A, El-Din ES.
Int J Dermatol. 2012;51(5):535-41.
Hydroxyurea-induced dermatomyositis is a rare drug-induced dermatomyositis characterized by skin lesions identical to classic dermatomyositis without clinical or laboratory evidence of myositis.
22515579
 FEMALE
Hydroxyurea-induced dermatomyositis: true amyopathic dermatomyositis or dermatomyositis-like eruption?
Nofal A, El-Din ES.
Int J Dermatol. 2012;51(5):535-41.
Hydroxyurea-induced dermatomyositis is a rare drug-induced dermatomyositis characterized by skin lesions identical to classic dermatomyositis without clinical or laboratory evidence of myositis.
22515579
 FEMALE
Hydroxyurea-induced dermatomyositis: true amyopathic dermatomyositis or dermatomyositis-like eruption?
Nofal A, El-Din ES.
Int J Dermatol. 2012;51(5):535-41.
Hydroxyurea-induced dermatomyositis is a rare drug-induced dermatomyositis characterized by skin lesions identical to classic dermatomyositis without clinical or laboratory evidence of myositis.